212 related articles for article (PubMed ID: 9322083)
21. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
22. Increased efficacy of human natural interferon alpha (IFN-alpha n3) versus human recombinant IFN-alpha 2 for inhibition of HIV-1 replication in primary human monocytes.
Fan SX; Skillman DR; Liao MJ; Testa D; Meltzer MS
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1115-22. PubMed ID: 8312053
[TBL] [Abstract][Full Text] [Related]
23. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
24. MxA gene expression in peripheral blood mononuclear cells from patients infected chronically with hepatitis C virus treated with interferon-alpha.
Meier V; Mihm S; Ramadori G
J Med Virol; 2000 Nov; 62(3):318-26. PubMed ID: 11055241
[TBL] [Abstract][Full Text] [Related]
25. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
[TBL] [Abstract][Full Text] [Related]
26. Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.
Scagnolari C; Casato M; Bellomi F; De Pisa F; Turriziani O; Coviello R; Pirro MR; Dianzani F; Antonelli G
Clin Diagn Lab Immunol; 2003 Jan; 10(1):70-7. PubMed ID: 12522042
[TBL] [Abstract][Full Text] [Related]
27. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
28. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
[TBL] [Abstract][Full Text] [Related]
29. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies neutralizing human leukocyte acid- and thermolabile interferon alpha.
Kontsek P; Borecký L; Lackovic V; Kontseková E; Sujanová Z; Novák M
Acta Virol; 1989 May; 33(3):254-61. PubMed ID: 2570512
[TBL] [Abstract][Full Text] [Related]
31. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha.
Wussow PV; Jakschies D; Freund M; Hehlmann R; Brockhaus F; Hochkeppel H; Horisberger M; Deicher H
Br J Haematol; 1991 Jun; 78(2):210-6. PubMed ID: 2064959
[TBL] [Abstract][Full Text] [Related]
32. Absence of neutralizing antibodies to interferon in condyloma acuminata and cancer patients treated with natural human leukocyte interferon.
Liao MJ; Axelrod HR; Kuchler M; Yip YK; Kirkbright E; Testa D
J Infect Dis; 1992 Apr; 165(4):757-60. PubMed ID: 1552208
[TBL] [Abstract][Full Text] [Related]
33. Detection and incidence of neutralizing antibodies to interferon-alpha-n1.
Weck PK; Leventhal BG; Brand C; Finter NB
J Interferon Res; 1989 Sep; 9 Suppl 1():S37-43. PubMed ID: 2553830
[TBL] [Abstract][Full Text] [Related]
34. High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.
Ross C; Svenson M; Hansen MB; Vejlsgaard GL; Bendtzen K
J Clin Invest; 1995 May; 95(5):1974-8. PubMed ID: 7738163
[TBL] [Abstract][Full Text] [Related]
35. Response to sequential treatment with lymphoblastoid interferon-alpha in patients with Ph+ chronic myeloid leukemia unresponsive to recombinant interferon-alpha (rIFN alpha 2a) and neutralizing-rIFN alpha 2a antibodies negative.
Russo D; Candoni A; Grattoni R; Minisini R; Rosti G
Haematologica; 1997; 82(3):348-50. PubMed ID: 9234589
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation.
Prümmer O; Bunjes D; Wiesneth M; Hertenstein B; Arnold R; Porzsolt F; Heimpel H
Bone Marrow Transplant; 1996 Apr; 17(4):617-23. PubMed ID: 8722365
[TBL] [Abstract][Full Text] [Related]
37. Neutralizing antibodies and serum interferon levels in the different stages of HIV infection.
Szabó B; Tóth FD; Kiss J; Ujhelyi E; Füst G; Horváth A; Hollán SR
Acta Virol; 1990 Apr; 34(2):164-70. PubMed ID: 1975977
[TBL] [Abstract][Full Text] [Related]
38. Comparison of antigenic properties of three interferon (IFN)-alpha 2 subvariants and establishement of a quantitative IFN-alpha 2 ELISA.
Karayianni-Vasconcelos G; Fuchsberger N; Skamlová Z; Kontsek P
Acta Virol; 1993 Dec; 37(6):509-14. PubMed ID: 8010188
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of anti-interferon antibodies in the serum of chronic hepatitis C patients treated with interferon-alpha.
Bonino F; Baldi M; Negro F; Oliveri F; Colombatto P; Bellati G; Brunetto MR
J Interferon Cytokine Res; 1997 Jul; 17 Suppl 1():S35-8. PubMed ID: 9241614
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to interferon in patients undergoing IFN therapy: an update.
Antonelli G
J Biol Regul Homeost Agents; 1995; 9(4):123-31. PubMed ID: 8844336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
